SG Americas Securities »

Eliem Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $60k 12k 5.12

More positions owned by SG Americas Securities

Apple (AAPL)
Facebook Inc cl a (META)
Spdr S&p 500 Etf (SPY)
Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
Visa (V)
UnitedHealth (UNH)
Alphabet Inc Class C cs (GOOG)
Invesco Qqq Trust Series 1 (QQQ)
iShares S&P 500 Index (IVV)
Progressive Corporation (PGR)
Vanguard S&p 500 Etf idx (VOO)
United Parcel Service (UPS)
SPDR Gold Trust (GLD)
Palo Alto Networks (PANW)

View all positions for SG Americas Securities

Top funds holding Eliem Therapeutics

RA Capital Management
Samsara BioCapital
Boxer Capital
BlackRock
Affinity Asset Advisors
T. Rowe Price Associates
Geode Capital Management
Driehaus Capital Management
Point72 Asset Management
Nan Fung Group Holdings
Northern Trust
Dr. Jeffrey R. Jay, M.D.
Monashee Investment Management
Ikarian Capital
TD Asset Management

View all funds holding Eliem Therapeutics